Echo Therapeutics Other Current Liabilities

Echo Therapeutics (ECTE) currently reports a other current liabilities of $1.9M as of September 2016. That compares with $620K in the prior-year period — up 210.9% year over year. Use the charts on this page to explore Echo Therapeutics's other current liabilities history and peer comparisons.

Echo Therapeutics's other current liabilities increased from $620K to $1.9M — a 210.9% year-over-year increase (period ending September 2016). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Echo Therapeutics reported $1.9M in other current liabilities as of September 2016. That compares with $620K in the prior-year period — up 210.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other current liabilities of $1.9M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Echo Therapeutics, and consider following ECTE for alerts when major investors trade the stock.